Vaxcyte, Inc. (PCVX)
60.69
+0.87
(+1.45%)
USD |
NASDAQ |
Apr 07, 16:00
60.71
+0.02
(+0.03%)
After-Hours: 20:00
Vaxcyte Market Cap : 8.864B for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Celldex Therapeutics, Inc. | 2.087B |
| Corcept Therapeutics, Inc. | 4.528B |
| Cytokinetics, Inc. | 8.138B |
| Syndax Pharmaceuticals, Inc. | 2.205B |
| Rhythm Pharmaceuticals, Inc. | 5.892B |
Market Cap Related Metrics
| PEG Ratio | -0.2295 |
| Price to Book Value | 3.301 |
| Price | 60.69 |
| Earnings Yield | -9.26% |
| PEGY Ratio | -0.2295 |